retatrutide side effects clinical trials 2025 Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Lilly's triple agonist achieves 16.8%

A major antioxidant involved in reducing oxidative stress, enhancing metabolic detoxification, and regulating the immune system, glutathione levels were found to have skyrocketed in metastatic cancer cells that invaded the lung

MBX-102/JNJ39659100, a novel non-TZD selective partial PPAR- agonist lowers triglyceride independently of PPAR- activation

It reflects the policy exclusion

Toxicol Sci 160:315328

Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition

NAC uniquely impacted pathways such as gluconeogenesis, mitochondrial electron transport chain, branched-chain fatty acid oxidation, phytanic acid peroxisomal oxidation, and glycine-serine metabolism